(Note: Foresight Acquisition Corp. II withdrew its IPO plans in an SEC filing dated July 28, 2022. Foresight II filed to go public in its S-1 dated June 8, 2021, with initial plans to sell 25 million units at $10 each to raise $250 million. The IPO was scaled back to 20 million units at $10 each – to raise $200 million – in an S-1/A filing dated Oct. 21, 2021. Each unit consisted of one share of our Class A common stock and one-half of one redeemable warrant. This was a NASDAQ listing.)

We initially intend to capitalize on the track record and experience of our management team and sponsor and focus our search in the technology-enabled consumer and consumer healthcare industries. 

Our team is led by Greg Wasson, the former CEO and president of Walgreens Boots Alliance (NASDAQ: WBA), the first global pharmacy-led, health, well-being, and beauty enterprise. Mr. Wasson is recognized throughout the drugstore and healthcare industry for transformational leadership, innovation, bold business decisions and executing on strategic long-term visions. Since retirement from WBA, Mr. Wasson formed his own family office, Wasson Enterprise. In this capacity, Mr. Wasson has invested in and nurtured a portfolio of investments in which he actively adds value through his ability to catalyze relationships for businesses, primarily in the capacity of customers, channel partners, key hires and strategic investors. 

Foresight II was formed as a partnership. It will be led by Greg Wasson, our chairman, as well as by Mike Balkin, our CEO, and two former co-portfolio managers of William Blair’s Small Cap Growth Investment Funds, along with other founders and advisors named (in the prospectus).